JILL
J.Jill, Inc.
JILL has lower modeled downside risk, despite its lower overall score.
LCID
Lucid Group, Inc.
LCID has the edge over JILL overall, supported by stronger valuation and stronger fundamentals.
JILL Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Strong |
JILL's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
LCID Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
JILL PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.6x | $11.88 | -47% |
| Fair | 8.9x | $15.86 | -29% |
| Forward | 9.5x | $22.43 | — |
| Expensive | 13x | $22.75 | +1.4% |
| Current | 13x | $22.43 | — |
Historical ranges are pointers, not guarantees.
JILL's PE is in its expensive range at 13x. If earnings grow as analysts expect, today's price would be 9.5x next year's earnings, in its fair range.
LCID PE Valuation
LCID has no meaningful PE right now: it lost money over the past year.
JILL Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for JILL, with profitability improving. However, they disagree widely on these estimates.
LCID Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses shrinking | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.
JILL Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.37 | +33% |
| Q3 2026 | $1.79 | -24% |
| Q2 2026 | $1.37 | -38% |
| Q1 2026 | $1.82 | -30% |
| Q4 2025 | $2.16 | -24% |
| Q3 2025 | $2.36 | -17% |
| Q2 2025 | $2.21 | -34% |
| Q1 2025 | $2.61 | +4% |
| Q4 2024 | $2.83 | +26% |
JILL has the edge over LCID on earnings quality, reporting a profit while its opponent remains loss making.
LCID Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$13.08 | -$2.57 |
| Q2 2026 | -$13.65 | -$2.35 |
| Q1 2026 | -$13.15 | -$1.25 |
| Q4 2025 | -$12.09 | +$0.41 |
| Q3 2025 | -$10.51 | +$2.49 |
| Q2 2025 | -$11.30 | +$0.40 |
| Q1 2025 | -$11.90 | +$0.40 |
| Q4 2024 | -$12.50 | +$1.10 |
LCID is still losing money, but less than at its worst: $13.08 per share over the past year, against $16.50 at its worst in mid-2023.
JILL Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $154.8M | +0.5% |
| Q2 2026 | $144.4M | -6% |
| Q1 2026 | $138.4M | -3.1% |
| Q4 2025 | $150.5M | -0.5% |
| Q3 2025 | $154M | -0.8% |
| Q2 2025 | $153.6M | -4.9% |
| Q1 2025 | $142.8M | -4.4% |
| Q4 2024 | $151.3M | +0.8% |
JILL's revenue grew through 2021 and has held roughly level since: $155M last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 16% | +4.8 points |
| Q2 2026 | 6.1% | -6.3 points |
| Q1 2026 | -0.1% | -3.7 points |
| Q4 2025 | 9.9% | -2.8 points |
| Q3 2025 | 11% | -3.9 points |
| Q2 2025 | 12% | -5.2 points |
| Q1 2025 | 3.6% | -3.5 points |
| Q4 2024 | 13% | -2 points |
JILL has the edge over LCID on profitability, with a higher operating margin.
LCID Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $350.3M | +4.1% |
| Q2 2026 | $405.3M | +56% |
| Q1 2026 | $282.5M | +20% |
| Q4 2025 | $522.7M | +123% |
| Q3 2025 | $336.6M | +68% |
| Q2 2025 | $259.4M | +29% |
| Q1 2025 | $235M | +36% |
| Q4 2024 | $234.5M | +49% |
LCID has the edge over JILL on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -245% | +35 points |
| Q2 2026 | -267% | +43 points |
| Q1 2026 | -350% | -56 points |
| Q4 2025 | -204% | +109 points |
| Q3 2025 | -280% | +105 points |
| Q2 2025 | -310% | +83 points |
| Q1 2025 | -294% | +128 points |
| Q4 2024 | -313% | +156 points |
LCID's operating margin was −245% last quarter, up 35 points from the same quarter a year ago, near the top of its range since 2020.
JILL Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $44.5M | +160% |
| Q2 2026 | -$881K | -128% |
| Q1 2026 | -$11M | -899% |
| Q4 2025 | $16M | +9.4% |
| Q3 2025 | $17.1M | +14% |
| Q2 2025 | $3.1M | -84% |
| Q1 2025 | $1.4M | -22% |
| Q4 2024 | $14.6M | -22% |
JILL has the edge over LCID on cash generation, producing positive trailing cash flow while its opponent burns cash.
LCID Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1B | -$84.2M |
| Q2 2026 | -$1.5B | -$463.2M |
| Q1 2026 | -$1.4B | -$849M |
| Q4 2025 | -$1.2B | -$417.1M |
| Q3 2025 | -$955.5M | -$333M |
| Q2 2025 | -$1B | -$271.6M |
| Q1 2025 | -$589.9M | +$125.1M |
| Q4 2024 | -$824.8M | -$77.6M |
LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.
JILL Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +98.7K shares |
| 1 year | -1.5% | -223K shares |
| 3 years | +3.9% | +564K shares |
| 5 years | +65% | +5.9M shares |
| Available history | +71% | +6.3M shares |
JILL has the edge over LCID on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $1.5M |
| Q2 2026 | $794,000 |
| Q1 2026 | $3.8M |
| Q4 2025 | $2M |
| Q3 2025 | $1M |
| Q2 2025 | $3.5M |
JILL spent $8M buying back its own shares over the past year.
LCID Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +3.3% | +12.5M shares |
| 1 year | +26% | +82.4M shares |
| 3 years | +73% | +166M shares |
LCID has 395M diluted shares, up 26% from a year ago.
| Quarter | Spent |
|---|---|
| Q4 2020 | $2.2M |
| Q1 2020 | — |
JILL Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.1x | Net Cash |
| Q2 2026 | 0.6x | Very low |
| Q1 2026 | 0.5x | Very low |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.4x | Net Cash |
| Q4 2024 | 0.3x | Very low |
| Q3 2024 | 0.4x | Very low |
JILL has more cash than debt.
LCID Net Leverage
LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
JILL Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 60.0 | Neutral |
| Stochastic | 69.5 | Neutral |
JILL's weekly RSI is 60 (neutral) and its Stochastic is 70 (neutral).
LCID Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 32.9 | Neutral |
| Stochastic | 7.1 | Oversold |
LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).
JILL PE vs Consumer Cyclical Sector
| Metric | JILL | Sector median | Relative |
|---|---|---|---|
| PE | 13x | 18x | 30% below |
| PE % | 81 | 47 | 34 pts above |
JILL is trading at 13x earnings, a 30% discount to the Consumer Cyclical sector's median of 18x.
LCID PE vs Consumer Cyclical Sector
LCID has no meaningful PE right now: it lost money over the past year.
JILL Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.7 | 5.5% below |
| 20 week MA | $21.0 | 6.8% above |
| 50 week MA | $17.1 | 31% above |
| 100 week MA | $17.8 | 26% above |
| 200 week MA | $22.4 | 0% above |
JILL has the edge over LCID on trend strength, trading above more of its moving averages.
LCID Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $3.53 | 7.9% below |
| 20 week MA | $4.88 | 33% below |
| 50 week MA | $7.33 | 56% below |
| 100 week MA | $15.4 | 79% below |
| 200 week MA | $31.9 | 90% below |
LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.
JILL Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $5.50 | $4.02 | -27% |
| 2021 | $4.02 | $16.8 | +319% |
| 2022 | $16.8 | $22.5 | +34% |
| 2023 | $22.5 | $25.8 | +14% |
| 2024 | $25.8 | $26.9 | +4.3% |
| 2025 | $26.9 | $14.5 | -46% |
| 2026 YTD | $14.5 | $22.4 | +55% |
JILL has the edge over LCID on returns for 2026, with the stronger performance.
LCID Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $98.9 | $100.4 | +1.5% |
| 2021 | $100.4 | $376.4 | +275% |
| 2022 | $376.4 | $67.0 | -82% |
| 2023 | $67.0 | $42.1 | -37% |
| 2024 | $42.1 | $32.0 | -24% |
| 2025 | $32.0 | $11.4 | -64% |
| 2026 YTD | $11.4 | $3.25 | -72% |
LCID has finished four years in a row lower, and it's down 72% so far in 2026.